Bottom line
TAISX vs SCHF: the short answer
TAISX (Nuveen Quant International Small Cap Equity Fund) and SCHF (Schwab International Equity ETF) are both mutual funds.
But SCHF is far broader, holding 1,479 positions to 449 for TAISX, so beyond the top names it adds exposure TAISX doesn't have.
SCHF is cheaper at 0.03% vs 0.82% — a difference of $79 a year per $10,000 invested.
Over five years, TAISX returned +8.7% a year vs +5.0% for SCHF (reporting dates differ).
Updated Nov 19, 2026
TAISX vs SCHF side by side
| TAISX | SCHF | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Nuveen / TIAA | Schwab |
| Category | International Stock | International Stock |
| Expense ratio | 0.82% | 0.03% |
| Annual cost per $10k | $82 | $3 |
| 10-yr cost on $10k (prospectus) | $1,014 | $39 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +35.7% | +3.5% |
| 5-yr return (annualized) | +8.7% | +5.0% |
| 10-yr return (annualized) | — | +5.4% |
| Best quarter | — | +17.0% |
| Worst quarter | — | −23.1% |
| Net assets (fund) | $1.4B | $66.5B |
| Number of holdings | 449 | 1,479 |
| Portfolio turnover | 112% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
TAISX and SCHF share none of their top holdings.
TAISX top 10
- iShares MSCI EAFE Small-Cap ETF — 2.80%
- iShares Core MSCI Emerging Markets ETF — 1.29%
- Unicaja Banco SA — 0.93%
- Centerra Gold Inc — 0.85%
- Diploma PLC — 0.79%
- GE Vernova T&D India Ltd — 0.75%
- State Str Navigator Secs L Tr — 0.74%
- Samsung E&A Co Ltd — 0.73%
- JOYY Inc — 0.72%
- Currys PLC — 0.71%
SCHF top 10
- Samsung Electronics Co Ltd — 3.32%
- SK hynix Inc — 2.81%
- ASML Holding NV — 2.10%
- HSBC Holdings PLC — 1.08%
- Roche Holding AG — 0.99%
- Novartis AG — 0.97%
- AstraZeneca PLC — 0.93%
- Royal Bank of Canada — 0.90%
- Nestle SA — 0.88%
- Shell PLC — 0.80%
FAQ
What is the difference between TAISX and SCHF?
Which is cheaper, TAISX or SCHF?
Should I own both TAISX and SCHF?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.